We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a ...

Morgan Stanley analyst Tejas Savant maintained a Hold rating on Illumina (ILMN – Research Report) today and set a price target of $136.00. The ...

What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 8.6% in the morning session after the company reported ...

The brokerage has a price target of $140. The headline numbers for Illumina (ILMN) give insight into how ... slipped 6% to $123.13, while PVH's stock dropped 1% to $82.49. Two of its Chinese ...

The placement of Illumina in China's unreliable entity list could have disruptive implications. Read why I remain bullish on ...

Tommy Hilfiger and Calvin Klein owner PVH (PVH) and biotechnology company Illumina (ILMN) were among the first casualties on ...

With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform. Finding good stocks at good prices ...

For momentum investors, upward or downward trends in a stock's price or earnings outlook take ... diagnostic and consumer genomics companies. ILMN sits at a Zacks Rank #3 (Hold), holds a Momentum ...